glp 1 medication for sleep apnea and GLP-1s may help some patients with but they're not GLP-1 Medications Show Promise as

The STRIDE trial evaluated semaglutide in patients with T2DM and PAD, finding a 13% improvement in maximum walking distance and a significant increase in ankle-brachial index, indicating improved perfusion

Functional medicine treatments , including probiotics, digestive enzymes, and herbal therapies

What makes you a candidate for semaglutide GLP-1 for weight loss

The typical elevation of 1-4 beats per minute falls within normal physiological variation and is comparable to the heart rate changes seen with routine daily activities

Patients with favorable variants often see 2+ pounds weekly loss

Reducing the risk of metabolic diseases: Inhibiting NNMT may counteract the adverse metabolic changes associated with obesity, such as fatty liver disease